Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-02 Sale | 2024-02-05 5:15 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $28.49 | $5,954 | 42,337 (Direct) | View |
| 2024-01-26 Sale | 2024-01-29 5:54 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 26,017 | $25.38 | $660,370 | 115,425 (Direct) | View |
| 2024-01-24 Sale | 2024-01-26 5:03 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 11,900 | $25.01 | $297,621 | 245,522 (Direct) | View |
| 2024-01-22 Sale | 2024-01-24 4:50 pm | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 35,066 | $22.68 | $795,191 | 189,176 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-09 Exercise | 2024-02-13 5:38 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 9,967 | $0 | 49,916 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:38 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 3,656 | $28.8 | 49,916 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-05 5:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $11.47 | 42,337 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-05 5:15 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 209 | $0 | 42,337 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 9,604 | $12.9 | 115,425 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 26,017 | $0 | 115,425 (Direct) | View |
| 2024-01-26 Exercise | 2024-01-29 5:54 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 16,413 | $3.26 | 115,425 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 5,900 | $12.9 | 245,522 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 11,900 | $0 | 245,522 (Direct) | View |
| 2024-01-24 Exercise | 2024-01-26 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 6,000 | $3.26 | 245,522 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 400 | $12.9 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 5,416 | $11.47 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 35,066 | $0 | 189,176 (Direct) | View |
| 2024-01-22 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 28,750 | $10.13 | 189,176 (Direct) | View |
| 2024-01-23 Exercise | 2024-01-24 4:50 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 500 | $3.26 | 189,176 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 9:09 pm | N/A 2034-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 63,000 | $0 | 131,532 (Direct) | View |
| 2024-01-06 Tax Withholding | 2024-01-09 9:09 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 4,147 | $20.4 | 131,532 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 9:09 pm | N/A 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 15,285 | $0 | 131,532 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 09:16 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 45,855 | $0 | 45,855 (Direct) | View |
| 2023-02-09 Tax Withholding | 2023-02-13 5:02 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 2,956 | $4.17 | 40,100 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 5:02 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 9,967 | $0 | 40,100 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 5:52 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 91,655 | $0 | 91,655 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-03-02 6:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 1,130 | $9.95 | 15,599 (Direct) | View |
| 2022-02-28 Exercise | 2022-03-02 6:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 4,105 | $0 | 15,599 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 4:39 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 75,000 | $0 | 97,558 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-11 4:39 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 4,966 | $0 | 97,558 (Direct) | View |
| 2022-02-09 Tax Withholding | 2022-02-11 4:39 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 1,473 | $10.13 | 97,558 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-03 5:54 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-06-22 Option Award | 2021-06-23 5:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 75,200 | $0 | 79,305 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 7:25 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 1,702 | $10.81 | 11,485 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 7:25 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 4,105 | $0 | 11,485 (Direct) | View |
| 2020-06-30 Tax Withholding | 2020-07-02 6:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 14,060 | $0.757 | 109,090 (Direct) | View |
| 2020-06-30 Exercise | 2020-07-02 6:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 41,050 | $0 | 109,090 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 6:01 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 369,400 | $0 | 369,400 (Direct) | View |
| 2019-06-10 Option Award | 2019-06-12 4:38 pm | N/A 2029-06-10 | EyePoint Pharmaceuticals Inc. | EYPT | Jones David Scott SVP & Chief Commercial Officer | 350,000 | $0 | 350,000 (Direct) | View |